As with all peptide therapies, protocol should be developed with a qualified provider who can assess your individual health context and goals
Bottom Line BPC-157 is an unapproved drug
If you experience worsening fatigue, jaundice (yellowing of skin or eyes), abdominal swelling, or confusion, contact your GP urgently, as these may indicate progression of liver disease requiring medical assessment
Causes and Characteristics Hormonal changes (PCOS, pregnancy, and birth control options) Sun exposure Genetic disposition Typical Patterns Symmetrical patches that appear on both sides of the face Recurring and resistant to any general treatments Highly common in women with medium to deeper skin tones Post-Inflammatory Hyperpigmentation (PIH) Post-Inflammatory Hyperpigmentation (PIH) occurs after skin inflammatory conditions like injury, burns, or acne
10.1038/s41380-018-0098-1 13 CooperA